Company: NIVFW
Filing Date: 2025-09-18
Form Type: F-1
Source: 0001213900-25-088927
Chunk: 201

Company: NewGenIvf Group Ltd
Filing Date: 2025-09-18
Form: F-1
Chunk 201
---
000 shares authorized and 113,852* and 50,747* shares issued and outstanding as of December 31, 2024 and 2023 respectively |     | $            |          — |   |     | $            |         — |   |
| Subscription receivable                                                                                                                                          |     |              |   (204,000 | ) |     |              |  (127,564 | ) |
| Additional paid-in capital                                                                                                                                       |     |              |    122,505 |   |     |              | 4,331,815 |   |
| Accumulated deficit                                                                                                                                              |     |              |   (985,994 | ) |     |              |  (461,351 | ) |
| Accumulated other comprehensive (loss) income                                                                                                                    |     |              |     18,875 |   |     |              |    (7,288 | ) |
| Equity attributable to the shareholders of the Company                                                                                                           |     |              | (1,048,614 | ) |     |              | 3,735,612 |   |
| Non-controlling interests                                                                                                                                        |     |              |   (433,143 | ) |     |              |  (490,051 | ) |
| Total shareholders’ equity                                                                                                                                       |     |              | (1,481,757 | ) |     |              | 3,245,561 |   |
| TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY                                                                                                                       |     | $            |  3,577,744 |   |     | $            | 4,486,996 |   |

| * | The shares as presented have been adjusted retrospectively for two Reverse Share Splits effected in February 2025 of 1 share for every 20 existing shares issued and in May 2025 of 1 share for every 10 existing share issued respectively. |

| ** | Re-presented as mentioned in Note 23 |

<div align='center'>The accompanying notes are an integral part of
these consolidated financial statements.

F-5

NEWGENIVF GROUP LIMITED
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)
FOR THE YEARS ENDED DECEMBER 31, 2024, 2023 AND 2022
(Stated in US Dollars)</div>

|                                                                                   |     | December 31, |       2024 |   |     |   |       2023 |